Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Granulomatous diseases - an update

News and interesting facts about pathomechanisms and treatment

    • Congress Reports
    • Dermatology and venereology
    • Genetics
    • RX
    • Studies
  • 4 minute read

Both infectious and noninfectious granulomatous dermatoses are very heterogeneous clinical pictures. Treatment is based on pathogenesis and is primarily anti-inflammatory, with corticosteroids still playing an important role. A new therapeutic target is the JAK-STAT pathway, and there are some recent study findings on this. The methodology of RNA sequencing used for this purpose provides insight into pathophysiologically relevant genetic features and reveals interesting correlations.

“Granulomatous dermatoses are an extremely diverse group of diseases,” explains Prof. Dr. med. Mario Fabri of the University Hospital of Cologne at this year’s meeting of the German Dermatological Society (DDG) [1]. With regard to pathomechanisms, progress has been made by modern high-throughput methods, but there are still many open questions. It is expected that further “omics” data will help to improve pathophysiological understanding. In addition to metabolomics and proteomics, “spatial transcriptions” (gene expression that can be localized on histological sections) are also used in the field of genomics. Regarding therapeutic options, recent studies have identified the JAK-STAT pathway as a potential therapeutic target. “JAK-STAT could be established as a new therapeutic target,” Prof. Fabri said.

Defense mechanism against infectious and non-infectious influences

Benign connective tissue nodules, called granulomas, can occur in all organs. “The granuolome, by definition, is a nodular collection of macrophages,” the speaker explained [1]. According to the histomorphologic structure of the granulomas, tuberculoid, sarcoid, collagenolytic, or palisade granulomas are classified, Pseudotuberculosis-type granulomas and foreign body granulomas are distinguished [2]. According to current knowledge, it is assumed that the formation of a granuloma represents a specific defense mechanism of the organism, whereby a central stimulus, which can be of infectious (mycobacteria) or non-infectious (foreign bodies) origin, results in the activation of skin antigen-presenting cells, which subsequently attract both granulocytes and lymphocytes to the tissue [2]. These inflammatory cells usually accumulate in a ring around the antigen-presenting cells and form the characteristic histological picture of the granuloma. Activation of tissue-derived macrophages phagocytose infectious agents or inert foreign bodies in an attempt to isolate and thus contain potentially virulent pathogens. It is therefore a kind of protective wall around material that cannot be eliminated, explains Prof. Fabri.

RNA sequencing to explore pathomechanisms.

“Molecular mechanisms have been shown primarily in animal models,” the expert said. In recent years, progress has also been made in research in humans. Analyses with modern high-throughput methods lead(ed) to a new understanding. Leprosy is an example of an infectious granulomatosis in which the pathogenesis has been studied by such modern methods. “Infectious granulomatoses can be caused by bacteria, parasites, fungi, as well as viruses,” the speaker explained. Leprosy is caused by the pathogen Mycobacterium leprae. In an article by Inkeles et al. [3] reports a study in which RNA sequencing was performed and analyzed using complex mathematical models. For example, researchers have found that there is a network of dendritic cells in tuberculoid leprosy in which matrix metalloproteinase 12 (MMP12) likely plays a major pathogenetic role.

Sarcoidosis and granuloma anulare: Corticosteroids still first choice

Primary therapy for sarcoidosis consists of corticosteroids, which may be administered topically or intralesionally; systemic administration may also be necessary [4,5]. Alternatively, hydroxychloroquine, methotrexate (MTX), or dapsone may be used for anti-inflammatory therapy. In addition, TNF-alpha blockers (off-label) have been shown to improve disease. However, latent tuberculosis must be ruled out before treatment is attempted (quantiferon test) [5].

 

 

In granuloma anulare (Fig. 1) , locally applied steroids are also the drugs of first choice [5]. Preferably applied topically in children, also intralesionally in adults. A variety of therapies have been described for disseminated forms. In addition to phototherapy (PUVA, UVA-1), treatment with systemic steroids, fumaric acid esters, dapsone, or hydroxychloroquine may be considered [5].

 

 

 

 

Evidence of efficacy for the use of the JAK inhibitor tofacitinib is also found in the literature, both in sarcoidosis (review 1) and granuloma anulare (review 2) [6,7]. Tofacitinib is a JAK inhibitor, which is also used in other skin diseases. Janus kinases (JAK) play a role in the phosphorylation of STAT molecules and are involved in the signal transduction of many different cytokines. The anti-inflammatory effect is based on the blockade of Janus kinases, on which cytokine receptors depend to exert their effect as inflammatory mediators via an intracellular signaling cascade. Further studies will show whether the previous findings are confirmed and which patients may benefit most from treatment with JAK inhibitors.

Congress: DDG Conference 2021

 

Literature:

  1. Fabri M: Pathomechanisms and therapeutic approaches in granulomatous diseases. Prof. Mario Fabri, MD, PV03: Plenary Lectures 3, DDG Meeting 2021, 04/16/2021.
  2. Mempel M: Granulomatous diseases. Brown-Falcos Dermatology, Venereology and Allergology. www.springermedizin.de/emedpedia/braun-falcos-dermatologie-venerologie-und-allergologie (last accessed 19.05.2021)
  3. Inkeles MS, et al: Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight 2016 Sep 22; 1(15): e88843.
  4. Graf L, Geiser T: The chameleon among systemic diseases: “Sarcoidosis,” Swiss Med Forum 2018; 18(35): 695-701.
  5. Mempel M: Noninfectious Granulomas of the Skin, 24. October 2017, https://derma.plus/journal/nicht-infektioese-granulome-der-haut (last accessed 19 May 2021).
  6. Damsky W, et al: Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis. N Engl J Med 2018; 379: 2540-2546.
  7. Wang A, et al: Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib. J Allergy Clin Immunol 2021; 147(5): 1795-1809.

 

DERMATOLOGIE PRAXIS 2021; 31(3): 36-37 (published 5/31/21, ahead of print).

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Granuloma anulare
  • sarcoidosis
Previous Article
  • Primary immunodeficiencies

Observe warning signs and react!

  • Partner Content
  • RX
View Post
Next Article
  • Spinal muscular atrophy

Clinical experience speaks for individual therapy management

  • Congress Reports
  • Neurology
  • Pediatrics
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Hand eczema: from diagnosis to treatment

Implementing sustainable, stage-appropriate measures

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Cystic fibrosis

Small spray – big footprint

    • Education
    • General Internal Medicine
    • Pediatrics
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Gastric outlet stenosis

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • RX
    • Surgery
View Post
  • 6 min
  • When the bones become more fragile: “Case Finding”

Fracture risk reduction in osteoporosis

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Biologics for plaque psoriasis

What increases the chance of a sustained remission?

    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 12 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • CME continuing education
    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 16 min
  • Pain and autism

Hurdles to pain treatment for autistic patients

    • CME continuing education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 5 min
  • Long-COVID

Increased risk with asthma and COPD

    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Hurdles to pain treatment for autistic patients
  • 2
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 3
    Treatment of comorbidities in older people
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.